Neurology Specific Literature Search   
 
[home][thesaurus]
    
Click Here to return To Results

 

Stroke Reperfusion Therapy Following Dabigatran Reversal with Idarucizumab in a National Cohort
Neurol 94:e1968-e1972, Barber, P.A.,et al, 2020
See this aricle in Pubmed

Article Abstract
Idarucizumab was used in 6% of all thrombolyzed patients in a national cohort during 2018, up from 1.3% in 2017. Idarucizumab appeared to be safe with similar clinical outcomes to routinely managed patients, despite a 22-minute door-to-needle time delay. Idarucizumab can facilitate thrombolysis in patients with stroke taking dabigatran.
 
Related Tags
(click to filter results - removes previous filter)

anticoagulant,reversal of
cerebrovascular accident,thrombolytic agents in treatment
dabigatran
efficacy
idarucizumab
non-vitamin K antagonist oral anticoagulants
safety
thrombolysis,mechanical

Click Here to return To Results